XML 22 R5.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (unaudited) - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive Loss [Member]
Accumulated Deficit [Member]
Convertible Preferred Stock [Member]
Preferred Stock [Member]
Beginning balance at Dec. 31, 2022 $ (45,654)   $ 2,127   $ (47,781) $ 80,627
Beginning balance (in shares) at Dec. 31, 2022   2,525,771       6,825,483
Retroactive application of reverse recapitalization   (1,175,989)       (3,177,808)
Adjusted balance, beginning of period (45,654)   2,127   (47,781) $ 80,627
Adjusted balance, beginning of period (in shares)   1,349,782       3,647,675
Exercise of stock options 121   121      
Exercise of stock options (in shares)   57,971        
Contribution from related party investors related to SAFEs 2,610   2,610      
Stock-based compensation expense 1,121   1,121      
Foreign currency translation adjustment (11)     $ (11)    
Net income (loss) (42,823)       (42,823)  
Ending balance at Dec. 31, 2023 (84,636)   5,979 (11) (90,604) $ 80,627
Ending balance (in shares) at Dec. 31, 2023   1,407,753       3,647,675
Exercise of stock options $ 1,624   1,624      
Exercise of stock options (in shares) 52,833 388,727        
Stock-based compensation expense $ 3,491   3,491      
Vesting of restricted stock 15   15      
Conversion of convertible preferred stock into common stock in connection with the Merger 80,627   80,627     $ (80,627)
Conversion of convertible preferred stock into common stock in connection with the Merger (in shares)   3,647,675       (3,647,675)
Issuance of common stock to related party investors upon redemption of the SAFEs 34,125   34,125      
Issuance of common stock to related party investors upon redemption of the SAFEs (in shares)   1,470,839        
Issuance of common stock under subscription agreement 94,601 $ 1 94,600      
Issuance of common stock under subscription agreement (in shares)   4,163,606        
Issuance of common stock upon the merger 68,891 $ 1 68,890      
Issuance of common stock upon the merger (in shares)   3,777,709        
Foreign currency translation adjustment 20     20    
Net income (loss) (57,982)       (57,982)  
Ending balance at Dec. 31, 2024 $ 140,776 $ 2 $ 289,351 $ 9 $ (148,586)  
Ending balance (in shares) at Dec. 31, 2024   14,856,309